Treprostinil PurReagent, >=98.0%
PurReagent
Properties
| Assay Purity | >=98% |
| M pt. | 126 - 127 °C |
| Density | 1.158 ± 0.06 g/cm3 |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H302,H319 |
| Precautionary Statement | P264 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313 - P501 |
| GHS Pictogram |
|
| Signal word | Warning |
| Storage Temp. | -20°C |
| Storage Class | 11 - Combustible Solids |
Description
Application
Treprostinil is administered through injection inhalation oral tablets or infusion therapy for treating pulmonary arterial hypertension and improving exercise capacity in affected patients.
Purpose
The main purpose of Treprostinil is to dilate pulmonary blood vessels reduce pulmonary artery pressure and decrease the workload on the heart
General Description
Treprostinil is a stable prostacyclin derivative with vasodilatory and antiplatelet properties that helps improve circulation and symptoms associated with pulmonary hypertension.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |